31 January 2019: The Federal Ministers give a final decision (positive) for this trialFile: bbe18bvw6_authorization.pdfTrial reference: Global study of a recombinant adeno-associated virus designed to address the monogenic root cause of Spinal Muscular AtrophyDoc type: Information related to the decision procedure
